The Relationship Between Cyberchondria and Health Perception and Anxiety Level in Pregnant Women: A Cross-sectional Study

NCT ID: NCT07192354

Last Updated: 2025-09-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

80 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-10-27

Study Completion Date

2026-01-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Pregnancy is a unique period in which women require extensive health information both to protect their own health and to prepare for motherhood. The literature indicates that pregnant women most frequently seek information on healthy nutrition, physical activity, fetal development, pregnancy symptoms, childbirth preparation, vaccination, and medication use. Although health professionals are considered reliable sources of information, due to limited accessibility, pregnant women often turn to the internet and social media. This increases the risk of exposure to inaccurate or incomplete information and may sometimes lead to cyberchondria. Moreover, during pregnancy, factors such as educational level, socioeconomic conditions, and family relationships contribute to the frequent occurrence of anxiety disorders, which can negatively affect the mother's quality of life and fetal development. Health perception, on the other hand, is an important concept that shapes individuals' health behaviors and responsibilities. However, studies examining the relationship between cyberchondria, anxiety levels, and health perception in pregnant women are limited. This study aims to reveal the relationship between health information-seeking behaviors, health perception, and anxiety levels in this special population of pregnant women.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cyberchondria Pregnancy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

CROSS_SECTIONAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Questionnaire and Physical Exam

Participants will be administered the Cyberchondria Severity Scale Short Form (CSS-12), Health Perception Scale, and State and Trait Anxiety Scale online via Google form.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Must be 18 years or older, pregnant, have access to the internet at any time, and have the ability to use it.
* Must be proficient in Turkish to understand the scales.

Exclusion Criteria

* Having a diagnosed psychiatric illness,
* Being a healthcare worker,
* Having cognitive impairment or mental or physical limitations to the extent that they cannot understand questions.
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Karabuk University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Nurcan Contarli

Lecturer

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Tarik OZMEN, PhD

Role: STUDY_CHAIR

Karabuk University

Nesibe Sumeyye KUTAHYALIOGLU, PhD

Role: PRINCIPAL_INVESTIGATOR

Karabuk University

Nurcan CONTARLI, PhD

Role: PRINCIPAL_INVESTIGATOR

Karabuk University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Karabuk University

Karabük, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Nurcan CONTARLI Lecturer, MSc

Role: CONTACT

0370 418 9160

Tarik OZMEN Professor, PhD

Role: CONTACT

0370 418 9029

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Nurcan CONTARLI Lecturer, MSc

Role: primary

0370 418 9160

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

KBUPTherapy

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.